Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
 Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
61.366
female
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$11-$25k
0
66,701
42,294.8125
44,193.1562
32.5
white
42.796875
69
0.397949
0.278992
1
0
0
no
0.8
0.7
no dnr
26
83
15.798828
80
20
36.39844
248
4.099609
0.399963
0.899902
137
7.389648
170
20
2,400
null
0
no(M2 and SIP pres)
0
527
1
82.92999
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
20,326
13,601.4219
14,092.8281
9.666664
white
15.599609
29
0.85791
0.80896
1
0
0
no
0.75
0.6
no dnr
14
73
7.199219
60
15
35.79688
null
null
null
2
142
null
105
41
1,275
3
0
no(M2 and SIP pres)
0
167
1
83.88196
female
0
35
ARF/MOSF w/Sepsis
ARF/MOSF
2
15
under $11k
0
83,738
31,256.8594
60,927.0625
38.25
black
30.699219
43
0.521973
0.405945
5
0
0
no
0.2
0.2
no dnr
35
111
2.799805
105
38
36.69531
151.65625
2.599609
1.699951
3.799805
145
7.40918
340
73
3,525
null
0
no(M2 and SIP pres)
0
864
0
68.50397
male
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
36,125
14,889.1406
26,628.0469
46
white
49.59375
70
0.158997
0.077988
1
0
0
no
0.3
0.3
dnr after sadm
6
67
22.5
120
40
35.69531
190
null
null
0.899902
145
7.469727
140
8
596
null
0
<2 mo. follow-up
0
9
1
74.91595
male
0
5
CHF
COPD/CHF/Cirrhosis
4
14
under $11k
0
6,488
2,851.5176
4,412.05859
19
white
15.298828
7
0.880981
0.80188
1
0
0
no
0.7
0.6
no dnr
5
64
22.199219
72
8
36.39844
122
null
null
1.099854
132
7.429688
263
18
1,655
0
1
null
1
862
0
41.26797
male
1
35
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
under $11k
0
54,511
24,352.5781
39,397.0312
25.75
white
40.398438
53
0.5979
0.490967
1
1
0
no
0.5
0.5
dnr after sadm
11
51
0.899902
108
31
35.59375
245.6875
2.5
1
1
141
7.40918
133
17
2,000
null
0
<2 mo. follow-up
0
35
1
90.18799
female
0
31
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
56,886
43,806.9062
46,281.8125
17.25
white
28.5
32
0.512939
0.395996
10
0
0
no
0.9
0.9
no dnr
31
110
15
80
20
37.19531
169.375
3
null
1.699951
139
7.299805
103
30
3,175
1
0
no(M2 and SIP pres)
0
862
0
62.80899
male
1
53
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
110,359
65,038.4375
83,454.875
24.75
white
24.796875
32
0.770996
0.696899
4
0
0
no
0.5
0.3
no dnr
53
83
2.799805
72
18
36.29688
null
2.899902
0.599976
1
133
null
94
9
2,500
null
0
<2 mo. follow-up
0
53
1
81.862
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
$11-$25k
0
13,348
5,834.8086
7,087.40625
11
white
24.898438
43
0.665894
0.56897
1
0
0
yes
0.95
0.9
no dnr
7
53
10.898438
80
15
38.89844
null
1.899902
null
13.199219
141
null
96
52
0
1
1
no(M2 and SIP pres)
1
859
0
92.59998
male
0
4
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,591
2,519.8281
2,690.46875
15
white
16.597656
25
0.767944
0.630981
1
0
0
yes
0.7
0.5
no dnr
4
63
14.599609
120
30
36.69531
216.65625
3.699707
0.5
0.799927
145
7.359375
100
9
null
0
null
SIP>=30
0.494751
424
1
63.23297
male
0
17
Colon Cancer
Cancer
2
9
null
0
21,338
12,039.3906
10,617.6875
14.666664
white
19.296875
23
0.787964
0.554932
1
0
0
metastatic
0.95
0.5
dnr after sadm
10
103
14.898438
80
20
36.09375
142.84375
null
null
1
136
7.339844
115
39
2,300
1
0
no(M2 and SIP pres)
0
200
1
37.16599
male
0
35
Cirrhosis
COPD/CHF/Cirrhosis
2
12
null
9
41,987
22,330.9375
10,011.1328
12
white
50
85
0.214996
0.068985
1
0
0
no
0.5
0.4
no dnr
35
97
14
80
25
36.69531
204.75
null
null
1.099854
143
7.369141
131
16
null
1
3
no(M2 and SIP pres)
3
857
0
75.409
male
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
4
9
under $11k
0
33,492
15,391.3984
15,235.4844
9.5
white
17.097656
15
0.813965
0.751953
15
1
0
no
0.9
0.85
no dnr
8
66
6.399414
116
8
36.09375
222
3
1.199951
3.799805
142
7.209961
112
58
4,150
0
null
no(M2 and SIP pres)
0.494751
856
0
72.534
male
0
5
COPD
COPD/CHF/Cirrhosis
3
8
null
9
6,225
3,391.3731
3,447.21875
16
white
25.796875
27
0.645996
0.46698
1
0
0
yes
0.3
0.1
no dnr
5
61
23.199219
130
10
38.69531
270
null
null
1.199951
147
7.389648
155
46
2,159
null
4
<2 mo. follow-up
4
29
1
80.66296
female
1
17
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
67,475
23,792.2969
46,603.875
56
white
30.199219
52
0.618896
0.514893
1
0
0
no
0.1
0.1
dnr after sadm
16
69
12.099609
125
28
35.59375
149
3.699707
null
6.199219
123
7.179688
159
89
1,395
null
null
<2 mo. follow-up
2.294434
17
1
75.90698
male
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
$25-$50k
0
61,597
38,251.2812
40,254.4688
46
white
35.695313
52
0.503906
0.386963
1
0
0
no
0.05
0.05
no dnr
21
63
7.599609
64
26
36.59375
285
null
null
1
141
7.399414
130
23
1,350
null
0
SIP>=30
0
855
0
88.99396
male
0
10
COPD
COPD/CHF/Cirrhosis
3
16
null
0
16,074
6,716.0938
12,173.6328
16
white
27.898438
41
0.531982
0.33197
1
0
0
no
0.7
0.5
dnr before sadm
-1
55
33
76
11
36.19531
88
2
null
0.699951
147
7.379883
116
11
3,531
0
null
no(M2 and SIP pres)
0.494751
293
1
52.73398
male
0
59
Coma
Coma
1
null
null
0
70,943
41,053.25
15,052.4062
19
white
25.296875
41
0.727905
0.677979
2
0
0
no
0.5
0.5
dnr after sadm
54
45
2.099609
118
20
38.69531
98.75
3.599609
4
2.5
138
7.279297
121
54
1,300
null
null
null
1.712891
853
0
80.37195
female
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
1
17
$25-$50k
0
42,111
29,083.7656
30,119.0469
35.666657
white
22
31
0.782959
0.712891
1
0
0
no
0.85
0.8
no dnr
21
107
7
70
20
36.09375
206.65625
3.799805
0.899902
1.299805
144
7.469727
95
16
2,200
null
null
SIP>=30
2.895996
120
1
80.24097
female
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
26,305
11,489.6016
16,048.9297
16
white
30.5
46
0.509888
0.392944
2
0
0
yes
0.9
0.9
no dnr
16
43
5.899414
117
42
39.19531
108
2.599609
0.5
1.299805
136
7.439453
215
19
3,770
1
0
no(M2 and SIP pres)
0
419
1
50.46698
male
0
8
COPD
COPD/CHF/Cirrhosis
4
10
under $11k
0
11,153
4,478.0234
8,908.04688
18
black
15.398438
13
0.925903
0.873901
1
0
0
yes
0.7
0.6
no dnr
8
60
15.898438
60
24
36.29688
91.65625
2.299805
null
1.699951
139
7.429688
113
34
3,075
0
0
no(M2 and SIP pres)
0
851
0
70.20898
male
0
14
Cirrhosis
COPD/CHF/Cirrhosis
1
12
$25-$50k
0
18,113
10,003.5156
8,457.25781
5.333332
white
17.296875
37
0.773926
0.639893
1
0
0
no
0.8
0.6
no dnr
14
103
5.199219
68
22
37.69531
263.3125
null
null
3.5
131
7.40918
245
65
2,395
1
2
SIP>=30
2
279
1
79.71497
female
0
19
COPD
COPD/CHF/Cirrhosis
7
12
under $11k
26
18,665
11,108.2734
10,894.8672
10
white
21.699219
31
0.599976
0.409973
1
1
1
yes
0.5
0.2
dnr before sadm
-1
59
10.599609
69
20
36.69531
178.3125
3.599609
1.799805
2.399902
138
7.15918
85
33
850
null
7
<2 mo. follow-up
7
26
1
38.39798
male
0
127
ARF/MOSF w/Sepsis
ARF/MOSF
2
15
under $11k
0
308,151
174,160.875
205,494.25
48.25
white
33.898438
44
0.674927
0.579956
14
0
1
no
0.5
0.5
no dnr
127
103
5.599609
70
20
36.69531
null
null
null
1.699951
143
null
103
32
1,310
null
3
adl>=4 (>=5 if sur)
3
850
0
72.487
male
1
15
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
86,066
48,466.7188
51,779.4375
37
black
39.398438
67
0.292969
0.181976
23
0
1
no
0.7
0.5
dnr before sadm
0
63
6.099609
80
20
36.09375
null
null
1.599854
1.899902
135
null
98
27
2,000
null
null
<2 mo. follow-up
4.946289
15
1
71.17896
female
0
12
Lung Cancer
Cancer
2
16
$25-$50k
0
17,762
11,561.0938
10,735.1094
27.5
black
16.296875
26
0.707886
0.424988
1
1
0
metastatic
0.75
0.5
no dnr
12
56
26.097656
72
28
36.09375
null
1.299805
24.398438
2.399902
112
null
477
28
1,040
0
0
no(M2 and SIP pres)
0
408
1
63.767
female
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
59,345
33,678.8438
40,554.8438
28.75
white
17.199219
20
0.87793
0.834961
2
1
0
no
0.5
0.75
no dnr
26
80
6.199219
80
20
36.09375
266.625
2.5
null
0.899902
134
7.5
124
11
1,100
1
0
no(M2 and SIP pres)
0
848
0
91.98395
female
0
3
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
under $11k
0
5,355
2,215.8594
3,479.26953
null
white
14.798828
10
0.842896
0.78894
1
0
0
no
null
null
dnr after sadm
1
107
8.298828
80
15
36.09375
484
2.5
null
2.399902
138
7.339844
192
36
1,300
null
null
no(M2 and SIP pres)
2.695801
658
1
70.87994
male
0
6
Lung Cancer
Cancer
3
12
null
0
5,514
3,357.1543
3,557.30859
11
white
31.597656
31
0.301941
0.051994
1
0
0
metastatic
0.8
0.3
no dnr
6
119
9.599609
140
12
34.59375
150
2.199707
null
0.799927
144
7.429688
90
54
2,955
4
5
<2 mo. follow-up
5
42
1
77.65399
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
14,591
6,149.5938
10,684.1562
15
white
25.898438
25
0.727905
0.643921
1
1
0
no
0.9
0.8
no dnr
10
53
13.199219
72
10
38.29688
80
2.599609
null
2.599609
130
7.319336
121
62
2,362
null
null
null
3.114746
844
0
59.58398
male
0
48
MOSF w/Malig
ARF/MOSF
1
20
>$50k
0
106,109
59,733.1875
68,911.875
24.5
white
34.5
58
0.352966
0.235992
1
0
0
metastatic
0.9
0.8
no dnr
48
61
7.5
112
40
37.59375
122.4375
3.199707
null
0.899902
141
7.399414
139
39
1,130
null
0
no(M2 and SIP pres)
0
258
1
42.69998
male
0
4
COPD
COPD/CHF/Cirrhosis
3
14
under $11k
0
6,088
1,507.1191
6,243.46875
5
hispanic
17.5
27
0.946899
0.908936
1
0
0
no
0.98
0.96
no dnr
4
107
12.398438
111
36
38.79688
156
3.699707
null
0.899902
145
7.459961
105
31
1,640
0
null
null
0.494751
845
0
40.745
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
17
$11-$25k
0
21,615
8,890.4766
13,112.7344
16
white
23.296875
34
0.881958
0.839966
1
0
0
no
0.7
0.65
no dnr
12
60
20.796875
114
32
37.89844
220
null
null
1.199951
134
7.479492
116
23
2,878
0
null
null
0.494751
843
0
84.58899
male
0
7
CHF
COPD/CHF/Cirrhosis
2
17
$25-$50k
0
12,772
5,564.2031
5,248.6875
14
white
18.199219
22
0.820923
0.707886
1
0
0
no
0.75
0.5
no dnr
7
53
22.597656
69
28
38
234.28125
3.099609
0.5
6.699219
127
7.369141
162
84
2,260
0
0
no(M2 and SIP pres)
0
273
1
38.21997
female
0
65
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
0
165,549
97,381.375
96,217.125
24
black
27.898438
64
0.794922
0.727905
9
0
0
no
0.7
0.6
no dnr
65
113
6.899414
65
13
36.29688
null
3.699707
0.5
0.899902
139
null
176
11
2,400
null
null
no(M2 and SIP pres)
2.452148
781
1
66.57098
female
0
17
MOSF w/Malig
ARF/MOSF
2
8
under $11k
9
21,336
10,116.6641
14,810.6953
10.666664
hispanic
20
38
0.74292
0.661987
1
0
0
yes
1
0.9
no dnr
17
83
6.099609
80
20
36.09375
null
3.299805
1.699951
1.599854
138
null
65
30
300
2
0
no(M2 and SIP pres)
0
251
1
72.09296
female
1
66
Coma
Coma
2
12
$11-$25k
61
92,723
53,217.9375
72,852.375
19
black
18.199219
37
0.385986
0.311951
15
1
0
no
0.8
0.75
dnr after sadm
12
93
8.699219
70
20
36.09375
null
null
0.399963
6.5
133
null
111
97
1,200
null
2
null
2
66
1
42.99799
male
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
0
58,702
33,407.1562
37,522.1562
26
white
35.59375
52
0.623901
0.519897
9
0
0
no
0.5
0.5
no dnr
23
55
16.898438
78
10
35
65
2
0.599976
0.599976
137
7.389648
144
4
1,906
0
0
null
0
839
0
68.88196
male
0
7
COPD
COPD/CHF/Cirrhosis
4
13
$11-$25k
0
8,507
4,556.7773
5,845.58984
7
white
20.296875
47
0.758911
0.618896
1
1
0
metastatic
0.8
0.6
no dnr
7
60
11.599609
80
36
33.79688
96.65625
2.5
2.099609
2.399902
149
7.529297
85
54
1,735
1
0
no(M2 and SIP pres)
0
177
1
70.20398
female
0
6
COPD
COPD/CHF/Cirrhosis
4
11
$11-$25k
0
6,931
3,673.6504
1,297.81934
13
white
20.097656
29
0.838989
0.735962
1
0
0
no
0.95
0.9
no dnr
6
107
4.599609
69
28
38.19531
null
null
null
1.5
134
null
333
17
3,480
2
null
no(M2 and SIP pres)
1.838867
837
0
92.33899
female
0
24
ARF/MOSF w/Sepsis
ARF/MOSF
3
18
under $11k
0
34,012
20,204.1719
21,715.9844
22.666656
white
26.898438
51
0.630981
0.527954
1
1
0
no
0.75
0.75
no dnr
24
52
8.5
81
8
38.89844
295
null
null
1.099854
139
7.419922
101
18
2,212
0
null
SIP>=30
0.494751
147
1
85.34399
female
0
30
Coma
Coma
2
null
null
26
41,743
23,544.8438
22,831.5
17
white
17.5
30
0.483948
0.41095
1
0
0
yes
0.3
0.1
dnr after sadm
1
93
6.799805
60
20
37.59375
318
null
null
1
141
7.5
95
26
null
null
3
adl>=4 (>=5 if sur)
3
836
0
87.71497
male
1
3
Coma
Coma
0
null
null
0
7,018
5,242.0508
5,069.41797
17
white
41.195313
89
0.056
0.028999
1
0
0
no
null
null
dnr after sadm
1
80
20.597656
110
25
37.79688
null
2.599609
null
1.199951
133
null
93
21
1,475
null
null
<2 mo. follow-up
2.151856
3
1
49.155
male
0
21
Cirrhosis
COPD/CHF/Cirrhosis
7
16
>$50k
0
46,039
26,825.8281
26,029.7969
22.666656
white
28.796875
46
0.706909
0.546997
1
1
0
no
0.8
0.75
dnr after sadm
13
60
22.199219
108
30
38.59375
135
2.899902
1.399902
1
136
7.319336
164
26
2,140
3
3
<2 mo. follow-up
3
32
1
87.44397
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
7,418
2,254.0938
6,433.62891
17
white
34.59375
69
0.369995
0.251953
1
0
0
yes
0
0
dnr after sadm
1
45
7.699219
54
26
38.79688
170
2
7.399414
0.899902
139
7.379883
88
40
2,450
null
null
<2 mo. follow-up
2.854981
4
1
71.74799
female
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
null
0
68,313
34,881.2188
36,946.6875
26
white
22.199219
37
0.80896
0.745972
1
1
0
no
0.6
0.5
no dnr
16
74
6
72
24
36.79688
176.1875
null
null
0.799927
137
7.289062
98
8
1,650
0
0
no(M2 and SIP pres)
0
829
0
32.75598
female
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
2
17
under $11k
0
22,857
12,762.8438
4,844.19922
21
white
28.296875
40
0.849976
0.79895
1
0
0
no
0.99
0.99
no dnr
16
147
11.298828
78
6
38.39844
89
3.199707
0.699951
1.199951
147
7.339844
149
31
2,090
1
1
SIP>=30
1
828
0
80.22498
female
0
8
Lung Cancer
Cancer
1
12
under $11k
0
7,970
4,700.3672
4,924.38672
2
white
20.199219
37
0.594971
0.276978
1
0
0
metastatic
0.8
0.3
dnr after sadm
1
77
6.799805
80
25
36.39844
136.65625
4.099609
0.799927
1.399902
141
7.319336
104
23
2,720
1
6
<2 mo. follow-up
6
23
1
79.65796
male
1
7
MOSF w/Malig
ARF/MOSF
2
null
null
0
9,602
6,555.2578
5,145.31641
8
white
30.5
59
0.430969
0.310974
1
1
0
metastatic
0.1
0
dnr after sadm
1
127
15
110
8
36.39844
194
2
null
6.199219
137
7.419922
73
44
95
null
3
<2 mo. follow-up
3
7
1
74.72095
male
0
4
CHF
COPD/CHF/Cirrhosis
3
16
>$50k
0
5,136
2,833.5059
2,667.56836
9
white
17.796875
29
0.856934
0.764893
1
1
0
no
0.2
0.1
no dnr
4
61
9.699219
108
32
36.69531
266.625
2.299805
1.099854
1.299805
143
7.55957
145
21
1,160
null
null
no(M2 and SIP pres)
2.106445
824
0
68.50696
female
0
12
Lung Cancer
Cancer
1
12
null
0
12,682
7,578.1133
7,094.25
7.5
white
6.899414
16
0.853882
0.67688
1
0
0
metastatic
0.7
0.2
no dnr
12
67
8.898438
76
24
36.59375
306.0625
null
null
2.299805
139
7.419922
298
33
928
null
null
<2 mo. follow-up
2.239746
41
1
59.79498
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
6
null
null
0
33,532
22,360.375
17,212.5156
35
black
35.398438
67
0.588989
0.480957
2
1
0
no
0.6
0.4
dnr after sadm
5
48
55.59375
70
0
38.19531
128
null
null
0.799927
131
7.419922
144
9
4,675
null
null
<2 mo. follow-up
3.238281
5
1
92.32599
female
1
6
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
21,252
14,635.0859
11,433.4688
35
white
32.398438
60
0.487976
0.369995
1
0
1
no
0.25
0.25
dnr before sadm
0
101
7.599609
60
28
36.09375
163.3125
3.699707
0.599976
0.899902
139
7.469727
227
12
1,850
null
null
<2 mo. follow-up
6.123047
6
1
73.63696
female
0
9
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
8,924
5,092.6602
5,050.61719
10
white
17.699219
20
0.860962
0.769897
1
1
0
no
0.9
0.75
no dnr
9
83
6.099609
100
25
35.59375
271.375
null
null
1.199951
142
7.419922
103
28
800
1
2
SIP>=30
2
821
0
82.57397
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
17
$11-$25k
0
52,314
27,385.3438
25,607.7344
13
white
24.296875
30
0.734985
0.651978
1
0
0
no
0.7
0.5
no dnr
14
115
12.599609
156
14
36.29688
252.375
2.699707
null
2.399902
139
7.469727
146
55
1,913
null
null
no(M2 and SIP pres)
3.111816
821
0
61.728
male
0
9
CHF
COPD/CHF/Cirrhosis
4
13
$11-$25k
0
12,263
6,591.2969
6,762.46875
18.5
white
18
16
0.860962
0.769897
1
0
0
yes
0.9
0.8
no dnr
9
135
13.898438
60
25
37.79688
238.09375
null
0.599976
1.299805
136
7.319336
108
25
2,170
0
0
no(M2 and SIP pres)
0
821
0
81.021
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
null
0
71,731
48,839.4062
46,667.0625
28.5
white
31
49
0.409973
0.289978
13
0
0
yes
0.1
0.1
no dnr
7
33
19.398438
68
44
40
347
null
null
2.199707
136
7.419922
547
39
64
null
0
<2 mo. follow-up
0
7
1
79.68195
female
1
8
MOSF w/Malig
ARF/MOSF
2
null
null
0
44,745
26,816.8125
19,279.625
42.5
white
28.199219
35
0.577881
0.46698
1
0
0
yes
0.8
0.6
dnr after sadm
4
100
12.5
70
25
36.69531
428.5625
2.399902
7.299805
1.399902
126
7.549805
335
43
2,020
null
null
<2 mo. follow-up
2.443359
8
1
75.18695
female
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
null
0
7,456
4,245.8906
3,948.84961
14
black
22.898438
16
0.787964
0.718994
1
0
0
no
1
1
no dnr
5
46
15.898438
109
8
35.89844
238.09375
3.099609
null
1.599854
135
7.419922
204
26
253
0
0
no(M2 and SIP pres)
0
819
0
62.26099
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
0
39,981
21,077.875
16,336.7578
8.333328
white
24.199219
25
0.681885
0.588989
3
0
0
metastatic
0.5
0.1
dnr after sadm
2
111
7.199219
69
36
38.29688
196.65625
3.199707
null
2.799805
136
7.15918
272
36
2,115
2
0
no(M2 and SIP pres)
0
120
1
66.51294
female
0
5
COPD
COPD/CHF/Cirrhosis
5
null
null
0
4,732
2,705.3906
2,484.89844
10
white
17.699219
25
0.850952
0.753906
1
0
0
yes
0.9
0.8
no dnr
5
63
14
130
35
36.59375
150
2.299805
0.199982
0.799927
145
7.519531
111
12
1,180
null
null
null
3.896973
818
0
70.20099
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
$11-$25k
0
22,622
13,765.7031
11,433.25
11
white
18.597656
29
0.85791
0.80896
1
0
0
no
0.95
0.95
no dnr
11
100
8.5
110
25
36.69531
null
3.399902
null
1.099854
137
null
209
28
800
0
0
no(M2 and SIP pres)
0
817
0
75.66296
female
0
24
Lung Cancer
Cancer
2
16
>$50k
0
30,159
16,960.3906
4,497.60938
7.666664
white
24.898438
17
0.482971
0.164978
1
1
0
metastatic
0.9
0.5
dnr after sadm
16
73
6.599609
120
35
35
457.125
2.899902
1
2.5
142
7.529297
227
61
550
1
3
adl>=4 (>=5 if sur)
3
74
1
73.06
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
$25-$50k
0
31,491
16,079.4531
16,632.9375
30.5
white
23.398438
21
0.706909
0.61792
3
0
0
yes
1
1
no dnr
10
80
6.099609
80
25
36.69531
276.1875
null
null
1.799805
139
7.449219
116
41
null
0
1
no(M2 and SIP pres)
1
816
0
81.73297
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
28,287
21,679.875
19,889.0469
25
white
21.898438
45
0.727905
0.643921
1
0
1
yes
0.3
0.3
dnr after sadm
3
87
13.599609
68
20
36.5
null
4.299805
0.699951
0.899902
139
null
124
20
1,750
null
null
<2 mo. follow-up
5.37207
47
1
84.82098
female
1
13
ARF/MOSF w/Sepsis
ARF/MOSF
2
18
>$50k
0
45,150
35,746.5
26,955.625
32.5
white
30.796875
46
0.578979
0.468994
1
0
1
no
0.8
0.8
dnr after sadm
7
53
14.798828
106
10
39.29688
108.32812
2.299805
0.599976
8.199219
147
7.429688
109
40
0
null
6
<2 mo. follow-up
6
13
1
49.82898
male
1
12
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
32,057
18,602.5156
16,752.6719
12
black
28.296875
34
0.658936
0.560913
3
0
1
metastatic
0
0
dnr after sadm
1
163
5.399414
150
37
38
72
2.5
0.599976
0.799927
142
7.369141
163
31
1,625
null
null
<2 mo. follow-up
4.806641
12
1
68.31995
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
15,734
11,297.625
8,246.88281
9.5
white
20.398438
24
0.843994
0.789917
1
0
0
no
0.9
0.9
no dnr
7
103
9.398438
60
20
36.09375
null
null
null
1.399902
140
null
129
44
2,275
0
1
no(M2 and SIP pres)
1
813
0
47.87399
male
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
null
0
124,925
87,454.0625
63,851.0625
39.5
white
40
55
0.569946
0.458984
1
0
0
no
0.1
0.1
no dnr
28
56
4.399414
48
22
36.09375
null
3.099609
0.599976
1.099854
143
null
106
14
1,370
null
1
no(M2 and SIP pres)
1
813
0
70.35199
female
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
9
100,587
59,188.5625
56,933.3438
11.333328
hispanic
21.699219
37
0.719971
0.633911
48
1
0
no
0.7
0.7
no dnr
17
83
7
80
35
35.59375
366.625
null
0.399963
1.199951
136
7.429688
107
14
2,980
1
1
no(M2 and SIP pres)
1
118
1
85.63196
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$11-$25k
0
55,663
null
null
21.333328
white
34.5
58
0.295959
0.184998
7
0
0
yes
0.8
0.7
no dnr
19
69
15.099609
66
20
36.09375
111.65625
2.099609
null
3.299805
139
7.439453
432
129
2,400
3
null
null
2.510742
811
0
64.08197
male
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
null
0
37,130
24,575.8281
15,632.1094
19
black
22.796875
45
0.768921
0.694946
2
1
0
yes
0.8
0.7
no dnr
17
63
7.099609
120
42
36.89844
135
3.199707
1.199951
0.799927
146
7.429688
131
17
1,010
0
0
no(M2 and SIP pres)
0
221
1
77.59296
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
null
9
37,632
24,508.875
21,132.0469
13.666664
white
22.398438
42
0.632935
0.529907
9
1
0
yes
0.25
0.05
dnr after sadm
1
101
4.899414
55
25
36.19531
266.625
4.399414
0.5
0.699951
144
7.439453
117
15
3,200
3
1
<2 mo. follow-up
1
17
1
76.78595
female
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
8,474
5,556.4961
4,709.59766
10
white
13.298828
30
0.893921
0.855957
1
0
0
no
0.99
0.9
no dnr
5
105
16
80
28
36.29688
138.3125
2.599609
0.799927
0.699951
142
7.40918
136
20
1,550
null
null
no(M2 and SIP pres)
1.78125
808
0
74.32996
male
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
6
12
$11-$25k
9
27,511
17,544.0156
9,628.41406
14.333328
white
19.699219
32
0.769897
0.695923
1
1
1
yes
0.1
0
dnr after sadm
3
100
null
90
25
36.09375
242.84375
null
0.299988
1.099854
133
7.359375
163
22
null
null
null
<2 mo. follow-up
5.783203
14
1
58.34598
male
0
13
Colon Cancer
Cancer
2
16
>$50k
0
20,169
11,726.9375
7,897.62891
15.5
white
15
16
0.852905
0.67395
1
0
0
metastatic
0.9
0.7
no dnr
13
82
27.398438
70
24
36.09375
197.125
2.699707
0.5
1.099854
138
7.369141
86
22
1,600
1
0
no(M2 and SIP pres)
0
690
1
52.98599
female
1
33
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
>$50k
41
165,799
115,003.688
82,986.625
38.5
white
30.597656
66
0.593994
0.485962
1
1
0
no
0.1
0.05
dnr after sadm
25
93
6.099609
60
15
37
null
2.799805
null
0.699951
134
null
249
25
null
null
4
<2 mo. follow-up
4
33
1
42.17899
male
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
95,443
63,887.2812
50,689.1875
23
black
24.898438
49
0.815918
0.753906
14
1
0
no
0.95
0.9
no dnr
28
110
4.899414
110
32
38.29688
183.3125
null
null
0.899902
143
7.489258
121
9
4,685
null
0
SIP>=30
0
802
0
70.11896
female
0
35
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
null
0
72,087
49,218.4688
40,064.7812
29
white
45.398438
63
0.260986
0.154999
1
0
0
no
0.25
0.15
no dnr
35
79
10.898438
140
38
38.09375
269.375
2.799805
0.599976
1.199951
138
7.379883
167
33
600
null
0
null
0
799
0
72.46497
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
5
12
$25-$50k
0
20,845
12,817.9688
6,751.56641
14
white
38.296875
44
0.363953
0.246979
1
0
0
yes
0.8
0.6
no dnr
13
48
10.398438
134
10
38.29688
170
null
null
1.299805
143
7.359375
121
32
505
0
0
<2 mo. follow-up
0
31
1
66.00397
female
0
8
MOSF w/Malig
ARF/MOSF
5
13
$11-$25k
0
20,343
14,605.9766
11,761.8984
20.5
hispanic
32.195313
42
0.408997
0.289978
1
1
0
metastatic
0.1
0
dnr after sadm
3
97
24.5
100
5
37.79688
111.65625
null
null
1.099854
137
7.449219
136
29
null
2
3
<2 mo. follow-up
3
30
1
72.38098
male
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
71,071
36,104.8125
34,603.875
15
white
31.699219
44
0.553955
0.440979
7
0
0
no
0.8
0.75
no dnr
17
129
5
106
34
38.19531
360
3.199707
1.399902
1.199951
142
7.449219
95
24
3,710
5
0
no(M2 and SIP pres)
0
89
1
74.875
female
0
7
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
7,262
3,990.8398
3,924.24805
12
other
13.699219
11
0.894897
0.823975
1
0
0
no
null
null
no dnr
7
47
18.597656
113
34
38.79688
53
2.299805
0.899902
0.899902
143
7.369141
154
17
1,968
1
1
no(M2 and SIP pres)
1
190
1
75.03094
female
0
27
COPD
COPD/CHF/Cirrhosis
2
null
null
0
59,400
40,212.1562
25,172.4688
19.5
white
23.597656
33
0.759888
0.618896
1
0
0
no
0.65
0.65
no dnr
27
99
24.199219
70
16
36.39844
334.25
null
0.799927
7.799805
137
7.359375
160
47
5
null
null
null
2.711914
794
0
30.752
female
0
39
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
under $11k
0
107,237
49,841.0312
55,241.625
12.25
white
25.699219
22
0.86499
0.81897
3
0
0
no
0.9
0.729
no dnr
39
57
6
144
36
40.19531
111.65625
null
null
1.299805
134
7.40918
169
21
3,775
null
null
null
2.979492
793
0
93.008
female
1
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
30,466
23,195.1875
15,860.0391
27.5
white
15.199219
38
0.834961
0.778931
1
0
0
no
0.8
0.7
dnr after sadm
5
56
10.298828
68
30
36.09375
450
3.099609
null
1.599854
143
7.339844
112
58
950
null
7
<2 mo. follow-up
7
10
1
43.92297
female
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
13
$25-$50k
0
8,939
5,789.7773
5,207.63672
12
white
18.699219
11
0.911987
0.879883
1
0
0
no
null
null
no dnr
5
120
14.298828
74
38
38.09375
null
2.699707
0.299988
3.799805
142
null
207
58
3,100
null
null
no(M2 and SIP pres)
1.797119
793
0
64.52795
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
under $11k
0
13,593
7,954.3398
8,211.36719
10
white
24.097656
27
0.807983
0.743896
1
0
0
no
0.9
0.9
no dnr
7
97
6.899414
80
20
37.79688
261.875
null
null
0.899902
143
7.399414
87
21
250
0
0
no(M2 and SIP pres)
0
792
0
73.89496
female
1
4
MOSF w/Malig
ARF/MOSF
1
12
under $11k
0
32,243
18,343.7344
16,782.7188
25
white
49.195313
111
0.023998
0.006
1
0
0
metastatic
null
null
dnr before sadm
-1
76
5.399414
58
28
36.59375
361.875
2.899902
0.899902
1.099854
135
7.439453
133
39
492
null
null
<2 mo. follow-up
2.431152
4
1
47.16498
male
0
11
Cirrhosis
COPD/CHF/Cirrhosis
3
14
>$50k
0
23,887
18,863.2188
15,334.5156
12
white
21.597656
45
0.833984
0.728882
1
0
0
no
0.8
0.8
no dnr
11
103
4.699219
60
15
36.69531
null
null
0.599976
1.199951
138
null
114
20
null
0
0
no(M2 and SIP pres)
0
791
0
82.409
male
0
46
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
>$50k
0
133,174
77,660.5
66,197.9375
31.25
white
17.699219
32
0.794922
0.727905
1
0
0
yes
0.99
0.95
dnr after sadm
22
150
31
102
38
36.29688
184
2
1.399902
1.5
127
7.40918
323
37
1,810
0
0
no(M2 and SIP pres)
0
118
1
65.58197
female
0
73
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
>$50k
0
194,085
124,043.188
118,328.938
29.75
white
30.5
49
0.671997
0.576904
2
0
0
no
0.25
0.25
no dnr
73
119
8
119
28
39.59375
null
3.199707
1.599854
7.099609
140
null
151
22
0
null
2
adl>=4 (>=5 if sur)
2
624
1
52.89499
female
0
34
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
$25-$50k
0
64,598
38,731.9062
33,413.875
16.5
white
31.699219
64
0.728882
0.645996
1
0
0
no
0.5
0.3
dnr after sadm
3
47
3.799805
108
26
36.39844
120
2
null
3.899902
136
7.419922
179
50
2,030
4
5
adl>=4 (>=5 if sur)
5
112
1
79.85199
female
0
28
MOSF w/Malig
ARF/MOSF
2
null
$11-$25k
0
38,248
22,160.5938
22,123.8438
14.75
white
26.597656
30
0.541992
0.427979
1
0
0
metastatic
0.8
0.75
dnr after sadm
4
52
10.099609
138
24
35
95
3.199707
null
1.399902
139
7.439453
132
38
1,550
null
1
SIP>=30
1
525
1
83.20898
female
1
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
$25-$50k
0
23,733
15,129.2266
12,450.2266
35
white
35.898438
51
0.35498
0.237976
8
0
0
no
0.3
0.2
dnr after sadm
1
113
12
114
28
37.59375
75
null
null
0.699951
134
7.199219
256
7
2,275
5
0
<2 mo. follow-up
0
6
1
74.45898
female
1
65
Coma
Coma
2
9
null
0
268,852
152,357.875
144,530.25
42.5
white
31.398438
42
0.407959
0.333984
1
0
0
no
null
null
no dnr
65
55
6.099609
49
16
36.79688
146.9375
3.099609
null
2.699707
139
7.419922
103
29
1,365
null
null
null
1.988525
65
1
53.75497
female
0
14
Cirrhosis
COPD/CHF/Cirrhosis
4
4
under $11k
0
20,960
11,320.4219
10,513.7344
12.666664
white
19.898438
41
0.824951
0.713989
1
1
0
no
0.6
0.5
no dnr
14
93
4.399414
80
20
36.69531
246.65625
null
null
1.199951
140
7.439453
87
30
1,800
5
6
null
6
82
1
89.60699
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
0
11,821
null
null
23
white
31.097656
61
0.459961
0.339966
1
0
0
yes
0.5
0.2
no dnr
6
53
8.199219
68
8
36.69531
200
3
1.299805
0.699951
142
7.389648
111
32
1,050
2
null
adl>=4 (>=5 if sur)
1.838867
211
1
76.35297
male
0
6
COPD
COPD/CHF/Cirrhosis
2
12
null
0
78,784
41,778.3438
37,698.1875
14
white
22.5
34
0.616943
0.430969
26
0
0
yes
0.9
0.7
dnr after sadm
1
103
4.699219
120
28
38.79688
343.3125
null
1.099854
0.699951
132
7.399414
117
6
3,525
0
0
no(M2 and SIP pres)
0
622
1
68.42999
male
1
52
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
under $11k
0
229,885
137,699.125
113,427.125
50.25
white
41.5
63
0.271973
0.164978
2
0
0
yes
0.6
0.6
dnr after sadm
14
63
8.099609
75
10
36.19531
230
2.799805
0.699951
1.099854
143
7.269531
196
53
850
null
2
<2 mo. follow-up
2
52
1